IDIS Monthly Update Information - July 2012
NEW DRUG TERM
ACORN
AD-ISF-35
APILIMOD
BMS-936559
CANAGLIFLOZIN
CHR-3996
COBICISTAT
ELOTUZUMAB
G-600
GLYCOMACROPEPTIDE
LIFITEGRAST
MDX-1100
ORG-25935
RADRETUMAB
REGORAFENIB
UC-781
VORTIOXETINE
CODE
92510288
14000814
14000084
10120299
68200453
10121023
44100110
10121024
40200030
40200029
52360029
82000567
28161221
10121025
10121022
8180879
28240885
NEW DISEASE TERM
FINDINGS, ABNORMAL GLUCOSE
CODE
790.2
DRUG NAME/CODE CHANGES
OLD TERM & CODENEW TERM & CODE
MDX-1106 10120273BMS-936558 10120273
FDA APPROVAL PACKAGES
Article Numbers 678687-678700: Avanafil, Stendra, FDA Approval Package for NDA 202276. FDA Approval Package 2012.
Article Numbers 678673-678686: Taliglucerase Alfa, Elelyso for Injection, FDA Approval Package for NDA 022458. FDA Approval Package 2012.
ADVISORY COMMITTEE MEETINGS
Article Numbers 679211-679216: Antiviral Drugs Advisory Committee Meeting, May 11, 2012. FDA Advisory Committee 2012.
BLACK BOX WARNINGS
Article Number 679234: Benazepril: FDA Black Box Warning. 2012.
Article Number 679233: Fluoroquinolones: FDA Black Box Warning. 2011.
Article Number 679232: Revised (10/18/2011): Gemifloxacin: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 605281]. 2011.
Article Number 679231: Revised (4/27/2012): Levofloxacin: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 605280]. 2012.
Article Number 679230: Revised (10/18/2011): Moxifloxacin: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 605279]. 2011.
Article Number 679229: Revised (2/09/2012): Norfloxacin: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 605278]. 2012.
Article Number 679228: Revised (2/25/2011): Ofloxacin: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 605277]. 2011.
Article Number 679227: Revised (11/15/2011): Ciprofloxacin: FDA Black Box Warning [IDIS Note: to View Outdated Warning See Article 605283]. 2011.
CONTINUING EDUCATION ARTICLES
Article Number 679409: Anonymous. Choice of Drugs for Heparin-Induced Thrombocytopenia (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 679408 and 679409]. Med Lett Drugs Ther 2012, 54:43-44.
Article Number 679408: Anonymous. Drugs for Menopausal Symptoms (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for All Articles in this Issue, Article Numbers 679408 and 679409]. Med Lett Drugs Ther 2012, 54:41-43.
Article Number 679248: Cada D J, Demaris K, Levien T L, Baker D E. Formulary Drug Reviews: Glucarpidase (0.15 CEU). Hosp Pharm 2012, 47:463-468.
Article Number 678458: Anonymous. Axitinib (Inlyta) for Advanced Renal Cell Carcinoma (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 678456-678458]. Med Lett Drugs Ther 2012, 54:47-48.
Article Number 678457: Anonymous. Mifepristone (Korlym) for Cushing's Syndrome (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 678456-678458]. Med Lett Drugs Ther 2012, 54:46-47.
Article Number 678456: Anonymous. Peginesatide (Omontys) for Anemia in Chronic Kidney Disease (0.1 CEU) [IDIS Note: The 1.0 Hour of CE Credit is for These Articles in this Issue, Article Numbers 678456-678458]. Med Lett Drugs Ther 2012, 54:45-46.
